Medical Condition News

RSS

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.

27 Feb 2020

Brain imaging may help predict when liquid biopsy will benefit individual glioblastoma patients

Tracking brain cancer with a blood test instead of a surgical biopsy may greatly improve quality of life for glioblastoma (GBM) patients and provide critical information for their care, but it is not feasible in all cases.

27 Feb 2020

Low fruit and vegetable consumption, increased body fat associated with anxiety disorders

New research from the Canadian Longitudinal Study on Aging shows that adults who have low fruit and vegetable intakes have a higher likelihood of being diagnosed with an anxiety disorder.

27 Feb 2020

Optimal preoperative definition of malnutrition varies by cancer type

The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.

26 Feb 2020

Advanced hollow nanomaterials can be used to create biosensors for early cancer detection

For the first time, a team of scientists at the University of Central Florida has created functional nanomaterials with hollow interiors that can be used to create highly sensitive biosensors for early cancer detection.

26 Feb 2020

Kessler researchers test trunk-strengthening program for stroke survivors with hemiplegia

Researchers at Kessler Foundation are studying a potential application of a trunk-strengthening program to improve posture, balance, and mobility in individuals recovering from stroke.

26 Feb 2020

Study reveals the effects of pre-surgical chemotherapy on breast cancer genome

Results from one of the first studies to determine the effects of pre-surgical, or neoadjuvant, chemotherapy on the breast cancer genome offer up two key insights.

26 Feb 2020

UC researchers uncover potential new treatment for patients with metastatic melanoma

Researchers at the University of Cincinnati have uncovered a potentially more beneficial treatment regimen for patients with metastatic melanoma.

26 Feb 2020

Widowed individuals experience a sharper cognitive decline than their married counterparts

The death of a spouse often means the loss of intimacy, companionship and everyday support for older adults.

26 Feb 2020

New multi-sensor tool quickly measures subtle changes in MS patients

Multiple sclerosis (MS) is a progressive, chronic disorder in which the body's immune system attacks the central nervous system, resulting in multiple adverse effects, from numbness, fatigue and impaired speech to loss of muscle control and vision.

26 Feb 2020

Use of hearing aids may delay cognitive decline in older adults

Wearing hearing aids may delay cognitive decline in older adults and improve brain function, according to promising new research.

26 Feb 2020

Study contributes to better understanding of rare KAT6A syndrome

A research team has described five new cases of a rare disease -known as KAT6A syndrome- of which there are only eighty dominant cases worldwide.

26 Feb 2020

New method to deliver an immune system 'uncloaking' device directly to cancer cells

Scientists at Johns Hopkins report they have designed and successfully tested an experimental, super small package able to deliver molecular signals that tag implanted human cancer cells in mice and make them visible for destruction by the animals' immune systems.

26 Feb 2020

Chronic cough could be eased with new drug

A pair of studies have shown that chronic cough and its distressing symptoms could be eased with the help of a new drug. Also, the drug does not have side effects that can restrict its use, explain the researchers. The results of the two studies are published in The Lancet Respiratory Medicine, and the European Respiratory Journal, respectively.

26 Feb 2020

Naturally occurring molecule could improve brain metabolism in patients with MS

N-acetylcysteine is a naturally occurring molecule that replenishes antioxidants and shows improved brain metabolism and self-reported improvements in cognitive function in patients with multiple sclerosis, according to a study published in the journal, Frontiers in Neurology.

26 Feb 2020

First patient in U.S. treated for atrial fibrillation using new type of ablation technology

Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.

26 Feb 2020

New form of gene editing slows ALS progression in mice

With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis - a debilitating and fatal neurological disease for which there is no cure.

26 Feb 2020

Study reports rising rates of ADHD diagnosis in veterans

Rates of diagnosed attention deficit-hyperactivity disorder in veterans receiving care in the VA health system more than doubled during the past decade, reports a study in the March issue of Medical Care.

26 Feb 2020

King's researchers launch largest ever study into eating disorders

Researchers at King's College London have launched the largest ever study into eating disorders. Partnering with the National Institute for Health Research BioResource and the eating disorder charity Beat, they aim to recruit at least 10,000 people in England who have experienced an eating disorder at some point in their life to a pioneering new study that aims to unlock the secrets of eating disorders.

26 Feb 2020

$Investigational drug reduces heartburn severity in patients with refractory GERD$

Investigational drug reduces heartburn severity in patients with refractory GERD

An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.

26 Feb 2020

Medical Condition News

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Brain imaging may help predict when liquid biopsy will benefit individual glioblastoma patients

Low fruit and vegetable consumption, increased body fat associated with anxiety disorders

Optimal preoperative definition of malnutrition varies by cancer type

Advanced hollow nanomaterials can be used to create biosensors for early cancer detection

Kessler researchers test trunk-strengthening program for stroke survivors with hemiplegia

Study reveals the effects of pre-surgical chemotherapy on breast cancer genome

UC researchers uncover potential new treatment for patients with metastatic melanoma

Widowed individuals experience a sharper cognitive decline than their married counterparts

New multi-sensor tool quickly measures subtle changes in MS patients

Use of hearing aids may delay cognitive decline in older adults

Study contributes to better understanding of rare KAT6A syndrome

New method to deliver an immune system 'uncloaking' device directly to cancer cells

Chronic cough could be eased with new drug

Naturally occurring molecule could improve brain metabolism in patients with MS

First patient in U.S. treated for atrial fibrillation using new type of ablation technology

New form of gene editing slows ALS progression in mice

Study reports rising rates of ADHD diagnosis in veterans

King's researchers launch largest ever study into eating disorders

Investigational drug reduces heartburn severity in patients with refractory GERD

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News